FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
April 26, 2024 at 07:02 AM EDT
The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |